Healthcare -
Biotechnology - NASDAQ - US
$ 8.33
18 %
$ 1.34 B
Market Cap
-3.82
P/E
Price Target
Average
166.51%
Revenue Forecast
Estimate
2.26%
EBIT
Estimate
4.14%
Net Income
Estimate
30.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Novavax, Inc.
Wall Street analysts predict an average 1-year price target for NVAX of $22.2 , with forecasts ranging from
a
low of
$14 to a high of $31 .
NVAX Lowest Price Target
Wall Street Target
14 USD
68.07%
NVAX Average Price Target
Wall Street Target
22.2 USD
166.51%
NVAX Highest Price Target
Wall Street Target
31 USD
272.15%
REVENUE FORECAST
Revenue Forecast Chart NVAX
EBIT FORECAST
EBIT Forecast Chart NVAX
NET INCOME FORECAST
Net Income Chart NVAX